| Authors: |
Burman RJ; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK., Brodersen PJN; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK., Raimondo JV; Division of Cell Biology, Department of Human Biology, Neuroscience Institute and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, 7935, South Africa., Sen A; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK., Akerman CJ; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. Electronic address: colin.akerman@pharm.ox.ac.uk. |
